Avascular necrosis market
Avascular Necrosis Market, by Drug Type (Non-steroidal anti-inflammatory drugs (Ibuprofen, and Naproxen Sodium), Osteoporosis drugs, Cholesterol-lowering drugs, Blood Thinners, and Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
- Dec 2021
- CMI2218
- 147 Pages
- Excel & Pdf
- Pharmaceutical
Avascular necrosis or osteonecrosis is the death of bone tissue due to a lack of blood supply. It majorly affects the long bones of the body such as,
- Hip Avascular Necrosis
- Shoulder Avascular Necrosis
- Knee Avascular Necrosis
- Ankle Avascular Necrosis
- Wrist Avascular Necrosis
The common symptoms of avascular necrosis are as follows-
- Early joint pain
- Increased joint pain as bone and joint begins to collapse
- Limited range of motion due to pain
Avascular necrosis is diagnosed with X-rays, magnetic resonance imaging (MRI), computed tomography scan (CT), or by nuclear bone scan.
The global avascular necrosis market is estimated to be valued at US$ 605.0 Mn in 2021 and is expected to exhibit a CAGR of 6.0% over the forecast period (2021-2028).
Global Avascular Necrosis Market - Impact of the Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdown in various countries across the globe have impacted the financial status of businesses across all sectors. The private healthcare sector is one such sector, which has been majorly impacted by the pandemic. When a person gets infected with COVID-19, there is an initial phase where the virus replicates and grows in the body. This is followed by inflammation, so steroids are administered to lower this inflammation. Due to prolong and excessive use of steroids, many patients are experiencing problems such as avascular necrosis (AVN).
The use of steroids to treat COVID-19 patients has led to avascular necrosis (AVN) or bone death. According to a news article published by The News Minute, in July 2021, 10-15 avascular necrosis patients have been treated per month in Apollo Hospitals, India. The high number of patients are those who were detected tested positive to coronavirus.
Thus, the impact of COVID-19 will drive the global avascular necrosis market over the forecast period.
Figure 1: Global Avascular Necrosis Market Share (%) Analysis, By Drug Type, 2021
Increasing number of drug approvals from regulatory bodies is a major factor driving the global avascular necrosis market growth over the forecast period
Market players are focusing on gaining drug approvals from regulatory bodies, which is expected to drive the growth of global avascular necrosis market during the forecast period. For instance, in December 2020, Novartis AG, a pharmaceutical company, announced that the European Commission (EC) had approved Leqvio (inclisiran) for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. Leqvio is a first-in-class small interfering RNA (siRNA) providing effective and sustained LDL-C reduction for patients with atherosclerotic cardiovascular disease (ASCVD).
Increasing number of product launches by the market players is expected to drive the global avascular necrosis market growth during the forecast period
Increasing number of partnerships by key players are expected to boost the market growth of the global avascular necrosis market during the forecast period. For instance, in August 2021, Dr. Reddy’s Laboratories Ltd., a pharmaceutical company announced the re-launch of over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA).
Avascular Necrosis Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2020 | Market Size in 2021: | US$ 605.0 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2021 to 2028 |
| Forecast Period 2021 to 2028 CAGR: | 6.0% | 2028 Value Projection: | US$ 909.8 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Solara Active Pharma Sciences Limited, Bayer AG, Rochem International Inc., Alkem labs., Dwarkesh Pharmaceuticals Private Limited., Novartis AG, GSK, Pfizer, Inc |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Global Avascular Necrosis Market – Restraints
Availability of alternative treatment is expected to hinder the growth of the global avascular necrosis market during the forecast period.
For instance, in May 2020, according to American Joint Replacement Registry (AJRR), 1.2 million patients with over 1.7 million hip and knee replacement procedures were registered in the U.S.
Global Avascular Necrosis Market – Regional Analysis
On the basis of region, the global avascular necrosis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold a dominant position in the global avascular necrosis market, owing to increasing number of inorganic growth strategies by market key players.
For instance, in April 2021, ECI Pharmaceuticals, LLC, a pharmaceutical company announced that it had entered into a distribution agreement with AiPing Pharmaceuticals, Inc., a pharmaceutical company, to manage the sales, marketing, and distribution of Ibuprofen 400 mg, 600 mg, 800 mg tablets, and Folic Acid 1 mg tablets in the U.S.
Figure 2: Global Avascular Necrosis Market Value (US$ Mn), by Region, 2020
Global Avascular Necrosis Market – Competitive Landscape
Major players operating in the global avascular necrosis market include Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Solara Active Pharma Sciences Limited, Bayer AG, Rochem International Inc., Alkem labs, Dwarkesh Pharmaceuticals Private Limited., Novartis AG, GSK, and Pfizer, Inc.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Route of Administration
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Product Launches/Approvals
- Regulatory Scenario
- Epidemiology
- PEST Analysis
- Acquisition and Collaboration Scenario
- Global Avascular Necrosis Market - Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Avascular Necrosis.
- Government Initiative
- Global Avascular Necrosis Market, By Drug Type, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Nonsteroidal anti-inflammatory drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Ibuprofen
- Naproxen Sodium
- Osteoporosis drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Cholesterol-lowering drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Blood Thinners
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Avascular Necrosis Market, By Route of Administration, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Ibuprofen
- Naproxen Sodium
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Avascular Necrosis Market, By Distribution Channel, 2017 – 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Avascular Necrosis Market, By Region, 2017 – 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2028
- Regional Trends
- North America
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Type, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Route of Administration 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Teva Pharmaceuticals Industries Ltd.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Dr. Reddy’s Laboratories Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Solara Active Pharma Sciences Limited.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Rochem International, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Alkem Labs.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Dwarkesh Pharmaceuticals Private Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- GSK
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceuticals Industries Ltd.*
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 42 market data tables and 40 figures on "Avascular Necrosis Market” – Global Forecast to 2028”